本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CG Oncology Inc.

74.12
+1.572.16%
盤前73.50-0.6200-0.84%04:50 EDT
成交量:79.57萬
成交額:5,874.76萬
市值:65.70億
市盈率:-27.21
高:74.59
開:72.66
低:72.66
收:72.55
52周最高:80.97
52周最低:35.64
股本:8,864.04萬
流通股本:6,473.22萬
量比:1.00
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-2.7235
每股收益(LYR):-2.0826
淨資產收益率:-26.41%
總資產收益率:-17.67%
市淨率:6.38
市盈率(LYR):-35.59

資料載入中...

2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/13

重要事件披露

Form 8-K - Current report